Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

ASTUSD
AirSwap / United States dollar
crypto Composite

Real-time
Nov 4, 2025 11:39:54 PM EST
0.0207USD-10.390%(-0.0024)3,386,198AST72,305USD
0.0207Bid   0.0210Ask   0.0003Spread
OverviewHistoricalDepthTrendsNewsNews
Composite
0.0207Coinbase
0.0207
Jan 28, 2022
08:01AM EST  Updates on OLUMIANT(r) (baricitinib) Phase 3 lupus program and FDA review for   PR Newswire
Jan 7, 2022
09:00AM EST  Axial Spondyloarthritis to U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)   PR Newswire
Jan 3, 2022
07:01AM EST  Generation Cupola360 SoC for Smart Cameras and Video Conferencing Systems   PR Newswire
Nov 18, 2021
08:41AM EST  IQST - iQSTEL Announces MOU To Acquire Telecom Company Supporting $75.5 Million   PR Newswire
Nov 9, 2021
08:31AM EST  OLUMIANT(r) Long-Term Safety Profile Established Up to 9.3 Years in Integrated   PR Newswire
Oct 7, 2021
08:17AM EDT  AbbVie's Upadacitinib (RINVOQ(r)) Met Primary and Most Ranked Secondary   PR Newswire
08:15AM EDT  AbbVie's RINVOQ(r) (upadacitinib) Met Primary and All Ranked Secondary   PR Newswire
Oct 2, 2021
06:07PM EDT  AbbVie to Showcase New Data at the United European Gastroenterology (UEG) Week   PR Newswire
Sep 30, 2021
08:30AM EDT  Dermatitis Across Patient Characteristics and Body Regions at EADV Virtual Congress   PR Newswire
05:56AM EDT  OLUMIANT(r) Significantly Improved Hair Regrowth to At Least 80% Scalp Coverage   PR Newswire
Sep 23, 2021
08:45AM EDT  AbbVie Presents New Data Analyses for Growing Dermatology Portfolio at the 30th   PR Newswire
Sep 16, 2021
08:01AM EDT  (RINVOQ(r)) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis   PR Newswire
Aug 24, 2021
08:01AM EDT  the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis   PR Newswire
Jul 16, 2021
10:01AM EDT  Lilly and Incyte provide update on supplemental New Drug Application for   PR Newswire
Jun 28, 2021
08:45AM EDT  AbbVie Gastroenterology Pipeline to be Featured at the 16th Congress of   PR Newswire
Jun 25, 2021
02:30AM EDT  CHMP Recommends Approval of RINVOQ(r) (upadacitinib) for the Treatment of   PR Newswire
Jun 2, 2021
07:30AM EDT  Treatment in Psoriatic Arthritis for More Than One Year at EULAR 2021 Virtual Congress   PR Newswire
07:00AM EDT  in Patients with Rheumatoid Arthritis to be Presented at EULAR 2021 Virtual Congress   PR Newswire
Jun 1, 2021
07:31PM EDT  OLUMIANT(r) Improved Pain, Physical Function and Morning Joint Stiffness in   PR Newswire
May 25, 2021
08:01AM EDT  AbbVie Showcases the Depth of its Rheumatology Portfolio with New Data   PR Newswire
May 11, 2021
06:43PM EDT  TMX Group Limited Reports Results for First Quarter of 2021   PR Newswire
May 4, 2021
06:43AM EDT  permission for restricted emergency use as a COVID-19 therapy via donations and licensing agreements   PR Newswire
Apr 23, 2021
10:01AM EDT  Atopic Dermatitis and Other Patient-Reported Outcomes in Phase 3 Study Analyses   PR Newswire
Apr 20, 2021
06:45AM EDT  Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata   PR Newswire
Apr 6, 2021
04:30PM EDT  Application for baricitinib for the treatment of moderate to severe atopic dermatitis   PR Newswire
Mar 3, 2021
06:45AM EST  Baricitinib is First JAK-Inhibitor to Demonstrate Hair Regrowth in Phase 3   PR Newswire
Jan 25, 2021
11:31AM EST  European Commission Approves AbbVie's RINVOQ(tm) (Upadacitinib) for the   PR Newswire
Dec 11, 2020
07:33AM EST  CHMP Recommends the Approvals of RINVOQ(tm) (Upadacitinib) for the Treatment of   PR Newswire
Dec 8, 2020
09:06AM EST  Synopsys Study Shows Open Source Security Top-of-Mind but Patching Too Slow   PR Newswire
Nov 19, 2020
05:21PM EST  Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment   PR Newswire
Nov 2, 2020
02:06PM EST  Lilly, Incyte Highlight Positive Data For Olumiant In Rheumatoid Arthritis   Benzinga
02:00PM EST  ACR 2020: Lilly and Incyte Highlight Positive Data for Olumiant(r) in   PR Newswire
Oct 31, 2020
10:45AM EDT  EADV 2020: Lilly and Incyte Showcase New Data for Baricitinib for the Treatment   PR Newswire
Oct 30, 2020
07:00AM EDT  Colgate-Palmolive Sees FY 2020 Adj EPS Growth Of 6%-7%   Benzinga
06:48AM EDT  Fall Clinical Dermatology 2020: Lilly And Incyte Showcase Positive New Data For Baricitinib In Adult Patients With Alopecia Areata   Benzinga
06:45AM EDT  Fall Clinical Dermatology 2020: Lilly and Incyte Showcase Positive New Data for   PR Newswire
Oct 29, 2020
02:05AM EDT  AbbVie to Present New Analyses from Pivotal Phase 3 Studies for RINVOQ(tm)   PR Newswire
Oct 26, 2020
02:38AM EDT  'Caged Bull' Bitcoin Crosses The $13K 'Breakout' Mark   Benzinga
Oct 8, 2020
11:40AM EDT  Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19   PR Newswire
Sep 18, 2020
07:45AM EDT  CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults   PR Newswire
Sep 14, 2020
06:30AM EDT  Baricitinib in Combination with Remdesivir Reduces Time to Recovery in   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC